<DOC>
	<DOCNO>NCT01210391</DOCNO>
	<brief_summary>The primary objective clinical trial compare growth infant ( express weight gain g/day ) consume new extensively hydrolyze formula ( EHF ) infant consume commercially available EHF .</brief_summary>
	<brief_title>Growth Infants Fed Extensively Hydrolyzed Infant Formula</brief_title>
	<detailed_description />
	<criteria>Healthy newborn singleton infant Fullterm ( &gt; = 37 week gestation ) Birth weight &gt; = 2500 &lt; =4500 g 14 Â± 3 day age enrollment Infant 's mother elect breastfeed baby exclusively formula feed minimum 3 day prior enrollment Study explain write information provide Parent/Caregiver Informed consent sign ( parent/legal representative ) Congenital illness malformation affect infant feed and/or growth Suspected know allergy cow 's milk protein Significant prenatal and/or postnatal disease Any readmission hospital ( except hyperbilirubinemia ) prior enrollment Infant receive oral IV antibiotic therapy 10 day prior enrollment Infant receive prescription medication ( exception topical antibiotic and/or treatment thrush ) frequent use counter medication except vitamin mineral supplement Infant receive probiotic seven day prior enrollment Infant currently participate another clinical study Infant 's family Investigator 's assessment expect comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>